![Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women - ScienceDirect Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1198743X14624393-gr1.jpg)
Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women - ScienceDirect
![Efficacy and Safety of a Novel Once-Daily Extended-Release Ciprofloxacin Tablet Formulation for Treatment of Uncomplicated Urinary Tract Infection in Women | Antimicrobial Agents and Chemotherapy Efficacy and Safety of a Novel Once-Daily Extended-Release Ciprofloxacin Tablet Formulation for Treatment of Uncomplicated Urinary Tract Infection in Women | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.49.10.4137-4143.2005/asset/1e83b815-740e-4e8b-a6f5-124cdc535030/assets/graphic/zac0100553340001.jpeg)
Efficacy and Safety of a Novel Once-Daily Extended-Release Ciprofloxacin Tablet Formulation for Treatment of Uncomplicated Urinary Tract Infection in Women | Antimicrobial Agents and Chemotherapy
![Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial - The Lancet Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial - The Lancet](https://www.thelancet.com/cms/attachment/2009248126/2032078126/gr1.gif)
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial - The Lancet
![Frontiers | Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis Frontiers | Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis](https://www.frontiersin.org/files/Articles/658095/fphar-12-658095-HTML/image_m/fphar-12-658095-g001.jpg)
Frontiers | Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
![PDF) Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies PDF) Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies](https://i1.rgstatic.net/publication/284728410_Ciprofloxacin_resistance_in_community-_and_hospital-acquired_Escherichia_coli_urinary_tract_infections_A_systematic_review_and_meta-analysis_of_observational_studies/links/565d248708ae1ef9298206ad/largepreview.png)